Synmosa Biopharma Corporation, a specialty pharmaceutical company, researches and develops, manufactures, markets, and distributes pharmaceutical and healthcare products under the Synmosa brand name in Taiwan. It offers its products in various therapeutic areas, including cardiovascular, respiratory, urology, sex hormone, and oncology. The company also provides its products in various forms, such as effervescent tablets, granules, nasal sprays, metered dosed inhalers, hormones, and other forms. In addition, it offers contract manufacturing services. The company also exports its products to South Africa, China, Hong Kong, Thailand, Singapore, Malaysia, Vietnam, Myanmar, Cambodia, Peru, Costa Rica, and Nicaragua. Synmosa Biopharma Corporation was incorporated in 1980 and is based in Taipei, Taiwan.
Metrics to compare | 4114 | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship Relationship4114PeersSector | |
---|---|---|---|---|
P/E Ratio | 20.1x | 0.0x | −0.7x | |
PEG Ratio | 1.17 | 0.00 | 0.00 | |
Price/Book | 2.0x | 0.0x | 2.6x | |
Price / LTM Sales | 2.7x | 0.0x | 3.1x | |
Upside (Analyst Target) | 4.7% | 0.0% | 55.4% | |
Fair Value Upside | Unlock | 0.0% | 9.9% | Unlock |